HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multiple sclerosis and the HLA-D region: linkage and association studies.

Abstract
Inheritance patterns of multiple sclerosis (MS) in multiplex families suggest a complex aetiology involving environmental and genetically determined components. The association between the HLA class II DR15, DQ6, Dw2 haplotype and MS has been well documented in patients with ancestral origins in Northern Europe. Conversely, linkage analysis of this region in multiplex families, derived from a population base, has generated negative results. Thus, given the Dw2 specificity association, evidence implicating this locus in disease susceptibility appears contradictory. We have collected and determined the HLA-DR and -DQ haplotypes of 115 sibling pairs with multiple sclerosis, and confirm a significant association with the Dw2-associated haplotype, both in index cases and their affected siblings compared with controls. However, using a sibling pair linkage analysis that restricts haplotype sharing probabilities to defined genetic models, we have not observed linkage of this region to susceptibility in MS. We discuss the basis for association and linkage and conclude that the DR15, DQ6, Dw2 haplotype does represent a susceptibility locus but its contribution to the pathogenesis is small; although it may interact epistatically with other susceptibility genes, this haplotype is not necessary for disease expression.
AuthorsH F Kellar-Wood, N W Wood, P Holmans, D Clayton, N Robertson, D A Compston
JournalJournal of neuroimmunology (J Neuroimmunol) Vol. 58 Issue 2 Pg. 183-90 (May 1995) ISSN: 0165-5728 [Print] Netherlands
PMID7759607 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-D Antigens
Topics
  • Adult
  • Aged
  • Female
  • Genetic Linkage
  • HLA-D Antigens (genetics)
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: